Stock Price
9.30
Daily Change
0.11 1.20%
Monthly
-1.90%
Yearly
30.62%
Q1 Forecast
9.00

Grifols reported EUR1.32B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
aTyr Pharma USD 22.13M 6.75M Sep/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Grifols EUR 1.32B 22.75M Sep/2025